The top barrier to entry for pharma brands considering a marketing play at the Super Bowl is the price point. A 30-second ad ...

Emarketer estimates that pharma TV advertising represents 8% ($4.6 billion) of the $60 billion spent on TV advertising per ...

Even folks who aren't into football tune into the Super Bowl for its ads, but this year there's some "big drama" around one ...

Many Americans support prohibiting commercials for prescription drugs on television. But enacting that ban could be ...

Last year marked the first time in Pfizer’s 175-year history that the drugmaker shelled out the requisite millions for ...

Unlike other brands that release their ads days or weeks ahead of the Big Game, Novartis is waiting to unveil its commercial ...

The GLP-1 compound drug sold by Hims and Hers is not approved by the FDA and its Super Bowl ad fails to list any risks ...

Patients in the United States pay the highest prescription drug prices in the world — on average four times what people in ...

AbbVie’s Skyrizi was responsible for the highest TV advertising outlay in pharma in most months of 2024, but 2025 is starting ...

Best yet, this growth isn't just coming from new customers. The revenue retention rate among Doximity's top 20 customers was ...

Emarketer estimates that pharma TV advertising represents 8% ($4.6 million) of the $60 billion spent on TV advertising per year.